Now Is A Good Time To Buy Veru Inc (NASDAQ: VERU)

During the recent session, Veru Inc (NASDAQ:VERU)’s traded shares were 0.5 million, with the beta value of the company hitting -0.47. At the last check today, the stock’s price was $0.73, reflecting an intraday loss of -4.10% or -$0.04. The 52-week high for the VERU share is $1.92, that puts it down -163.01 from that peak though still a striking 50.68% gain since the share price plummeted to a 52-week low of $0.36. The company’s market capitalization is $107.50M, and the average intraday trading volume over the past 10 days was 0.93 million shares, and the average trade volume was 592.65K shares over the past three months.

Veru Inc (VERU) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.60. VERU has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.07.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Veru Inc (NASDAQ:VERU) trade information

Veru Inc (VERU) registered a -4.10% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.10% in intraday trading to $0.73, hitting a weekly high. The stock’s 5-day price performance is -13.03%, and it has moved by -2.56% in 30 days. Based on these gigs, the overall price performance for the year is -18.66%. The short interest in Veru Inc (NASDAQ:VERU) is 12.54 million shares and it means that shorts have 20.88 day(s) to cover.

The consensus price target of analysts on Wall Street is $4, which implies an increase of 81.75% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3 and $5 respectively. As a result, VERU is trading at a discount of -584.93% off the target high and -310.96% off the low.

Veru Inc (VERU) estimates and forecasts

Statistics show that Veru Inc has outperformed its competitors in share price, compared to the industry in which it operates. Veru Inc (VERU) shares have gone down -55.22% during the last six months, with a year-to-date growth rate more than the industry average at 73.21% against 11.40. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 41.70% this quarter and then jump 12.50% in the quarter after that. In the rating firms’ projections, revenue will decrease -15.40% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 3.56M as predicted by 5 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 3.17M by the end of current fiscal year.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -19.79%. While earnings are projected to return 72.91% in 2024.

VERU Dividends

Veru Inc is due to release its next quarterly earnings on 2024-Dec-05. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. The average dividend yield of the company for the last 5 years is 3.71%.

Veru Inc (NASDAQ:VERU)’s Major holders

Veru Inc insiders own 14.10% of total outstanding shares while institutional holders control 42.72%, with the float percentage being 49.73%. ADAGE CAPITAL PARTNERS GP, L.L.C. is the largest shareholder of the company, while 132.0 institutions own stock in it. As of 2024-06-30, the company held over 7.86 million shares (or 5.3703% of all shares), a total value of $6.61 million in shares.

The next largest institutional holding, with 7.65 million shares, is of BLACKROCK INC.’s that is approximately 5.2267% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $6.44 million.